HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL

NCT01873807 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: IDA
RADIATION: TBI
DRUG: CTX
DRUG: VP-16

Sponsor

Nanfang Hospital, Southern Medical University